Human medicines European public assessment report (EPAR): Yargesa, miglustat, Date of authorisation: 22/03/2017, Revision: 7, Status: Authorised

Human medicines European public assessment report (EPAR): Yargesa, miglustat, Date of authorisation: 22/03/2017, Revision: 7, Status: Authorised

Human medicines European public assessment report (EPAR): Simulect, basiliximab, Date of authorisation: 09/10/1998, Revision: 30, Status: Authorised

Human medicines European public assessment report (EPAR): Simulect, basiliximab, Date of authorisation: 09/10/1998, Revision: 30, Status: Authorised

Human medicines European public assessment report (EPAR): Methylthioninium chloride Proveblue, methylthioninium chloride, Date of authorisation: 06/05/2011, Revision: 30, Status: Authorised

Human medicines European public assessment report (EPAR): Methylthioninium chloride Proveblue, methylthioninium chloride, Date of authorisation: 06/05/2011, Revision: 30, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness